Last reviewed · How we verify
NCT03723369
The Effect of Microneedling With Low Energy Laser in Androgenic Alopecia Patients.
NA trial testing accupuncture in Dermatologic Disease in 7 participants. Completed in 30 December 2019.
30 October 2019
Quick facts
| Lead sponsor | Shin Kong Wu Ho-Su Memorial Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 7 |
| Start date | 30 October 2018 |
| Primary completion | 30 October 2019 |
| Estimated completion | 30 December 2019 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- accupuncture
Conditions studied
- Dermatologic Disease — all drugs for Dermatologic Disease →
Sponsor
Shin Kong Wu Ho-Su Memorial Hospital
Who can join
Adults 20 to 60, male only, with Dermatologic Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Androgenetic alopecia is the most common type of hair loss in men, and affects approximately 50 percent of Caucasian men by age 50. The condition is characterized by the progressive loss of terminal hairs on the scalp in a characteristic distribution. The anterior scalp, mid scalp, temporal scalp, and vertex of the scalp are typical sites of involvement. "Male balding" and "male pattern hair loss" are additional terms used to refer to this condition. The aim of this study is to investigate the effect of microneedling in androgenic alopecia
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03723369
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Dermatologic Disease
Currently open trials in the same condition.
- NCT05898308 — Comparison of a Personalized Maintenance Therapy With the Standard Treatment in Pemphigus · Phase 4 · recruiting
- NCT06485050 — Photodynamic Therapy and Topical Antifungal for Onychomycosis in Patients With Diabetes. · NA · active not recruiting
- NCT05621369 — Psorcast Mobile Study · recruiting
- NCT03848962 — Collection and Distribution of Biospecimens for Novel Research Uses · recruiting
Other Shin Kong Wu Ho-Su Memorial Hospital trials
Trials by the same sponsor.
- NCT07324005 — Efficacy of Combining Ultrasound-Guided Needle Release of Transverse Carpal Ligament and Median Nerve Dextrose Water Hyd · NA · not yet recruiting
- NCT07207356 — Ultrasound Guided Transcutaneous Pulsed Radiofrequency for Cervical Radiculopathy · NA · recruiting
- NCT07032051 — Continuous Passive Motion to Prevent Ankle Contracture and Muscle Atrophy in Ventilated Patients · NA · not yet recruiting
- NCT06935877 — Additional Effect of Steroid on Hyaluronic Acid in Subdeltoid Bursitis · Phase 4 · not yet recruiting
- NCT06702046 — The Efficacy of Transcutaneous Pulsed Radiofrequency Acupuncture for Knee Osteoarthritis · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03723369 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Shin Kong Wu Ho-Su Memorial Hospital
- Last refreshed: 2 January 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03723369.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing